During the past decade, transcatheter occlusion of secundum atrial septal defects (Type II ASDs) has become a widely accepted alternative to surgical closure. To date, over 6,000 patients have been treated with the Cardia Intrasept™ PFO occluder (Cardia Inc., Burnsville, Minnesota) for the percutaneous closure of patent foramen ovale (PFO). This is a report of the use of a modified Intrasept device to close Type II ASDs in 4 patients.
|Number of pages||3|
|Journal||Journal of Invasive Cardiology|
|Publication status||Published - Mar 2007|
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine